Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple stepper test replace the clinic walk for lung patients?

NCT ID NCT06447831

Knowledge-focused Sponsor: Laval University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study evaluates the 6-minute stepper test as a way to measure exercise capacity in people with COPD or interstitial lung disease. Participants will perform the stepper test, a standard walk test, and a cycling test to see if the results match. The study also checks whether the test gives similar results when done in person versus via video call, and whether it is safe to do at home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
6-minute stepper test (a home-based exercise test)
What this could lead to
If validated, this test could offer a practical, remote way to monitor exercise capacity in people with chronic lung disease, potentially improving access to care.
What could go wrong
This is a validation study, not a treatment trial. It may show the test is not as accurate as traditional tests, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

89 people

The number who actually took part.

Started

Feb 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals with chronic obstructive pulmonary disease or interstitial lung disease followed in outpatient hospital settings

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult ≥ 40 years old * Diagnosis of chronic obstructive pulmonary disease (GOLDa 2 to 4) or of interstitial lung disease (\> 6 months) * Clinically stable for ≥ 4 weeks Exclusion Criteria: * Interstitial lung disease associated with connective tissue disease and sarcoidosis (often accompanied with multisystemic effects) * Unstable or severe cardiac condition * Invalidating rheumatologic or neurologic condition * Weight exceeding maximal limits of exercise equipment (e.g., 130 kg for the stepper) * Any other physical condition limiting or contraindicating exercise testing * Simultaneous participation in another study requiring changes in medication * Recent pulmonary rehabilitation (≤1 year, potential learning bias for the 6-minute walk test and the 6-minute stepper test) * For arm 1 only: Use of oxygen therapy (unable to perform gas analysis with oxygen therapy) * For arm 2 only: Participation in arm 1

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD, chronic obstructive pulmonary disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD, chronic obstructive pulmonary disease Interstitial lung disease

Contacts and locations

Locations

  • FormAction Santé

    Pérenchies, Hauts-de-France, 59840, France

  • Groupement des Hôpitaux de l'Institut Catholique de Lille

    Lille, Hauts-de-France, 59000, France

  • Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval

    Québec, Quebec, G1V 4G5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.